These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 16982882)
1. Functional dichotomy between OX40 and 4-1BB in modulating effector CD8 T cell responses. Lee SW; Park Y; Song A; Cheroutre H; Kwon BS; Croft M J Immunol; 2006 Oct; 177(7):4464-72. PubMed ID: 16982882 [TBL] [Abstract][Full Text] [Related]
2. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. Hendriks J; Xiao Y; Rossen JW; van der Sluijs KF; Sugamura K; Ishii N; Borst J J Immunol; 2005 Aug; 175(3):1665-76. PubMed ID: 16034107 [TBL] [Abstract][Full Text] [Related]
4. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine. Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726 [TBL] [Abstract][Full Text] [Related]
5. 4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function. Lee SJ; Myers L; Muralimohan G; Dai J; Qiao Y; Li Z; Mittler RS; Vella AT J Immunol; 2004 Sep; 173(5):3002-12. PubMed ID: 15322159 [TBL] [Abstract][Full Text] [Related]
6. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348 [TBL] [Abstract][Full Text] [Related]
7. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. Shuford WW; Klussman K; Tritchler DD; Loo DT; Chalupny J; Siadak AW; Brown TJ; Emswiler J; Raecho H; Larsen CP; Pearson TC; Ledbetter JA; Aruffo A; Mittler RS J Exp Med; 1997 Jul; 186(1):47-55. PubMed ID: 9206996 [TBL] [Abstract][Full Text] [Related]
8. Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice. Vidric M; Suh WK; Dianzani U; Mak TW; Watts TH J Immunol; 2005 Dec; 175(11):7288-96. PubMed ID: 16301634 [TBL] [Abstract][Full Text] [Related]
9. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo. Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071 [TBL] [Abstract][Full Text] [Related]
10. The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells. Ma BY; Mikolajczak SA; Danesh A; Hosiawa KA; Cameron CM; Takaori-Kondo A; Uchiyama T; Kelvin DJ; Ochi A Blood; 2005 Sep; 106(6):2002-10. PubMed ID: 15941918 [TBL] [Abstract][Full Text] [Related]
11. Modulation of cord blood CD8+ T-cell effector differentiation by TGF-beta1 and 4-1BB costimulation. Kim YJ; Stringfield TM; Chen Y; Broxmeyer HE Blood; 2005 Jan; 105(1):274-81. PubMed ID: 15353478 [TBL] [Abstract][Full Text] [Related]
12. Costimulation of T cells by OX40, 4-1BB, and CD27. Croft M Cytokine Growth Factor Rev; 2003; 14(3-4):265-73. PubMed ID: 12787564 [TBL] [Abstract][Full Text] [Related]
13. Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist. Redmond WL; Gough MJ; Charbonneau B; Ratliff TL; Weinberg AD J Immunol; 2007 Dec; 179(11):7244-53. PubMed ID: 18025166 [TBL] [Abstract][Full Text] [Related]
14. Cross-linking of 4-1BB activates TCR-signaling pathways in CD8+ T lymphocytes. Nam KO; Kang H; Shin SM; Cho KH; Kwon B; Kwon BS; Kim SJ; Lee HW J Immunol; 2005 Feb; 174(4):1898-905. PubMed ID: 15699116 [TBL] [Abstract][Full Text] [Related]
15. Enhanced CD4 T cell responsiveness in the absence of 4-1BB. Lee SW; Vella AT; Kwon BS; Croft M J Immunol; 2005 Jun; 174(11):6803-8. PubMed ID: 15905521 [TBL] [Abstract][Full Text] [Related]
16. 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner. Miller RE; Jones J; Le T; Whitmore J; Boiani N; Gliniak B; Lynch DH J Immunol; 2002 Aug; 169(4):1792-800. PubMed ID: 12165501 [TBL] [Abstract][Full Text] [Related]
17. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. Wen T; Bukczynski J; Watts TH J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439 [TBL] [Abstract][Full Text] [Related]
18. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival. Pulle G; Vidric M; Watts TH J Immunol; 2006 Mar; 176(5):2739-48. PubMed ID: 16493029 [TBL] [Abstract][Full Text] [Related]
19. 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Cooper D; Bansal-Pakala P; Croft M Eur J Immunol; 2002 Feb; 32(2):521-9. PubMed ID: 11828369 [TBL] [Abstract][Full Text] [Related]
20. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]